1.70
price up icon1.19%   0.02
after-market アフターアワーズ: 1.83 0.13 +7.65%
loading
前日終値:
$1.68
開ける:
$1.72
24時間の取引高:
361.45K
Relative Volume:
0.40
時価総額:
$184.08M
収益:
$27.08M
当期純損益:
$-37.00M
株価収益率:
-3.2692
EPS:
-0.52
ネットキャッシュフロー:
$-18.46M
1週間 パフォーマンス:
+5.59%
1か月 パフォーマンス:
+4.29%
6か月 パフォーマンス:
-32.27%
1年 パフォーマンス:
+25.93%
1日の値動き範囲:
Value
$1.665
$1.72
1週間の範囲:
Value
$1.61
$1.78
52週間の値動き範囲:
Value
$1.05
$5.17

Aclaris Therapeutics Inc Stock (ACRS) Company Profile

Name
名前
Aclaris Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
484-324-7933
Name
住所
701 LEE ROAD, WAYNE, PA
Name
職員
64
Name
Twitter
@aclaristx
Name
次回の収益日
2025-02-24
Name
最新のSEC提出書
Name
ACRS's Discussions on Twitter

ACRS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ACRS
Aclaris Therapeutics Inc
1.70 181.91M 27.08M -37.00M -18.46M -0.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
469.65 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.10 60.96B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.81 42.77B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.99 36.21B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.47 32.08B 3.81B -644.79M -669.77M -6.24

Aclaris Therapeutics Inc Stock (ACRS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-10 再開されました Piper Sandler Overweight
2025-05-28 開始されました Wedbush Outperform
2025-03-18 再開されました Cantor Fitzgerald Overweight
2024-12-23 アップグレード H.C. Wainwright Neutral → Buy
2024-11-20 アップグレード Cantor Fitzgerald Neutral → Overweight
2024-11-19 アップグレード BTIG Research Neutral → Buy
2024-11-19 アップグレード Jefferies Hold → Buy
2024-11-19 アップグレード Leerink Partners Market Perform → Outperform
2024-11-18 アップグレード Piper Sandler Neutral → Overweight
2024-01-22 ダウングレード H.C. Wainwright Buy → Neutral
2023-11-13 ダウングレード William Blair Outperform → Mkt Perform
2023-10-03 開始されました Evercore ISI Outperform
2022-12-14 開始されました Stifel Buy
2022-12-01 開始されました Goldman Buy
2022-10-06 開始されました BTIG Research Buy
2021-07-23 再開されました Jefferies Buy
2021-06-15 開始されました Piper Sandler Overweight
2021-04-21 開始されました H.C. Wainwright Buy
2019-10-22 アップグレード SVB Leerink Mkt Perform → Outperform
2019-09-06 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2019-06-27 ダウングレード SVB Leerink Outperform → Mkt Perform
2019-05-06 開始されました SVB Leerink Outperform
2018-03-28 再開されました Leerink Partners Outperform
2018-02-09 開始されました Guggenheim Buy
2017-06-16 開始されました Cantor Fitzgerald Overweight
2016-11-29 開始されました Leerink Partners Outperform
2016-09-30 開始されました JMP Securities Mkt Outperform
2016-06-10 開始されました Guggenheim Buy
2015-11-02 開始されました Citigroup Buy
2015-11-02 開始されました Jefferies Buy
すべてを表示

Aclaris Therapeutics Inc (ACRS) 最新ニュース

pulisher
12:50 PM

What are analysts’ price targets for Aclaris Therapeutics Inc. in the next 12 monthsHarness the power of proven investment plans - jammulinksnews.com

12:50 PM
pulisher
11:35 AM

What are the latest earnings results for Aclaris Therapeutics Inc.Build a balanced portfolio for long-term success - jammulinksnews.com

11:35 AM
pulisher
10:09 AM

How Resilient Is Aclaris Therapeutics Inc. Stock During Economic DownturnsLong Term Secure Gain Stocks - Newser

10:09 AM
pulisher
09:52 AM

Published on: 2025-07-27 19:20:18 - jammulinksnews.com

09:52 AM
pulisher
08:06 AM

How Efficient Is Aclaris Therapeutics Inc. at Controlling Operating CostsInsider Level Guidance - Newser

08:06 AM
pulisher
Jul 25, 2025

What drives Aclaris Therapeutics Inc. stock priceRapidly expanding wealth - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Aclaris Therapeutics Inc. Stock Analysis and ForecastConsistently high returns - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What institutions are buying Aclaris Therapeutics Inc. stock nowPhenomenal returns - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Aclaris Therapeutics Inc. stockFree Predictions - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Why Aclaris Therapeutics Inc. stock attracts strong analyst attentionFree Professional Portfolio Management - Newser

Jul 25, 2025
pulisher
Jul 23, 2025

LENZ Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is Aclaris Therapeutics Inc. a good long term investmentRapid capital growth - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Aclaris Therapeutics Inc. stock performs during market volatilityDaily Volume Leaders - Newser

Jul 22, 2025
pulisher
Jul 15, 2025

What makes Aclaris Therapeutics Inc. stock price move sharplyEntry Level Low Risk Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Aclaris Therapeutics Begins Phase 1 Clinical Trial for Bispecific Antibody ATI-052 Targeting Inflammatory Diseases - Insider Monkey

Jul 15, 2025
pulisher
Jul 15, 2025

13 Best Low Priced Pharma Stocks to Buy Now - Insider Monkey

Jul 15, 2025
pulisher
Jul 12, 2025

Piper Sandler Begins Coverage on Aclaris Therapeutics (NASDAQ:ACRS) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Aclaris Therapeutics' Recent Gains Improve Losses On Insider Purchases Worth US$1.50m - simplywall.st

Jul 11, 2025
pulisher
Jul 10, 2025

Plus Therapeutics (NASDAQ:PSTV) vs. Aclaris Therapeutics (NASDAQ:ACRS) Head-To-Head Survey - Defense World

Jul 10, 2025
pulisher
Jul 07, 2025

Aclaris Therapeutics Joins Russell 3000 and Russell 2000 Indexes - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jul 07, 2025
pulisher
Jun 30, 2025

Aclaris Therapeutics at HCW Conference: Strategic Moves and Future Plans By Investing.com - Investing.com Canada

Jun 30, 2025
pulisher
Jun 30, 2025

Aclaris Therapeutics joins Russell 3000 and Russell 2000 indexes - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Aclaris Therapeutics Added to the Russell 2000® and Russell 3000® Indexes - GlobeNewswire

Jun 30, 2025
pulisher
Jun 30, 2025

Aclaris Added to Russell Indexes: $10.6T in Benchmark Assets Now Track Biotech Stock - Stock Titan

Jun 30, 2025
pulisher
Jun 30, 2025

Aclaris Therapeutics, Inc.(NasdaqGS:ACRS) added to Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

Aclaris Therapeutics joins Russell 3000 and Russell 2000 indexes By Investing.com - Investing.com UK

Jun 30, 2025
pulisher
Jun 27, 2025

Aclaris Therapeutics to Participate in the H.C. Wainwright Inflammation & Immunology Virtual Conference - The Manila Times

Jun 27, 2025
pulisher
Jun 26, 2025

Aclaris Therapeutics to Present at H.C. Wainwright Inflammation & Immunology Virtual Conference on June 30, 2025 - Nasdaq

Jun 26, 2025

Aclaris Therapeutics Inc (ACRS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Aclaris Therapeutics Inc (ACRS) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Mehra Anand
Director
Nov 19 '24
Buy
2.25
666,666
1,499,998
710,030
Walker Neal
INTERIM PRESIDENT AND CEO
Aug 09 '24
Option Exercise
0.72
43,548
31,355
1,356,153
Leonard Braden Michael
10% Owner
Aug 05 '24
Buy
1.24
206,025
256,357
14,250,000
Leonard Braden Michael
10% Owner
Aug 02 '24
Buy
1.29
167,544
216,400
14,043,975
Leonard Braden Michael
10% Owner
Jul 30 '24
Buy
1.30
173,730
226,370
13,776,421
Leonard Braden Michael
10% Owner
Jul 31 '24
Buy
1.33
100,000
132,640
13,876,421
$23.40
price down icon 0.97%
$36.67
price up icon 0.22%
$103.95
price up icon 0.42%
$28.67
price up icon 3.99%
$115.31
price up icon 0.65%
biotechnology ONC
$291.47
price down icon 1.68%
大文字化:     |  ボリューム (24 時間):